We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
-1.15%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.4B
AUM Growth
+$334M
(+2.4%)
Cap. Flow
+$578M
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
50.45%
Holding
913
New
139
Increased
302
Reduced
176
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NGL Energy Partners
NGL
|
+$114M |
| 2 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$112M |
| 3 |
ANDX
Andeavor Logistics LP
ANDX
|
+$65.9M |
| 4 |
Cardinal Health
CAH
|
+$50.7M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$49.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$53.8M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$52.4M |
| 3 |
GRMN
Garmin
GRMN
|
+$50.8M |
| 4 |
The Mosaic Company
MOS
|
+$50.4M |
| 5 |
Valero Energy
VLO
|
+$50.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 58.22% |
| 2 | Healthcare | 2.73% |
| 3 | Financials | 2.71% |
| 4 | Materials | 2.68% |
| 5 | Consumer Discretionary | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Enanta Pharmaceuticals
ENTA
$372M
| $1.24M | 0.01% |
21,094
+2,347
| +13% | +$118K |
|
|
RVNC
227
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.23M | 0.01% |
34,279
+3,928
| +13% | +$113K |
|
228
Intel
INTC
$466B
| $1.22M | 0.01% |
26,472
+1,990
| +8% | +$86.8K |
|
229
Goldman Sachs
GS
$313B
| $1.22M | 0.01% |
4,775
+2,669
| +127% | +$655K |
|
230
Applied Materials
AMAT
$426B
| $1.22M | 0.01% |
23,767
-15,625
| -40% | -$846K |
|
|
AMRN
231
Amarin Corp
AMRN
$284M
| $1.2M | 0.01% |
+15,003
| New | +$1.03M |
|
232
Intuit
INTU
$81.1B
| $1.2M | 0.01% |
7,611
+3,827
| +101% | +$583K |
|
233
Sibanye-Stillwater
SBSW
$5.92B
| $1.2M | 0.01% |
247,147
-207,508
| -46% | -$1.01M |
|
234
Cadence Design Systems
CDNS
$90B
| $1.17M | 0.01% |
28,022
+11,117
| +66% | +$478K |
|
235
NVIDIA
NVDA
$5.01T
| $1.15M | 0.01% |
238,400
-217,080
| -48% | -$1.08M |
|
236
S&P Global
SPGI
$126B
| $1.15M | 0.01% |
6,798
+609
| +10% | +$99.4K |
|
|
STI
237
DELISTED
SunTrust Banks, Inc.
STI
| $1.14M | 0.01% |
17,665
+873
| +5% | +$53.3K |
|
238
AbbVie
ABBV
$458B
| $1.14M | 0.01% |
11,779
-531,104
| -98% | -$50.1M |
|
|
MDP
239
DELISTED
Meredith Corporation
MDP
| $1.14M | 0.01% |
17,235
+1,375
| +9% | +$82.9K |
|
|
ENLC
240
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $1.14M | 0.01% |
64,560
+7,944
| +14% | +$130K |
|
241
Essex Property Trust
ESS
$18.9B
| $1.13M | 0.01% |
4,683
-200
| -4% | -$50.5K |
|
242
Take-Two Interactive
TTWO
$43B
| $1.11M | 0.01% |
10,154
-601
| -6% | -$65.6K |
|
|
ACOR
243
DELISTED
Acorda Therapeutics
ACOR
| $1.11M | 0.01% |
432
+49
| +13% | +$139K |
|
244
Realty Income
O
$61.2B
| $1.11M | 0.01% |
20,078
-913
| -4% | -$49.5K |
|
245
Thor Industries
THO
$3.99B
| $1.1M | 0.01% |
7,326
+3,078
| +72% | +$428K |
|
246
Comcast
CMCSA
$79.1B
| $1.1M | 0.01% |
27,363
+1,364
| +5% | +$51.3K |
|
247
Heron Therapeutics
HRTX
$86.3M
| $1.09M | 0.01% |
+60,398
| New | +$985K |
|
|
MBT
248
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $1.09M | 0.01% |
107,106
+17,922
| +20% | +$185K |
|
|
VEDL
249
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $1.08M | 0.01% |
+51,900
| New | +$1.02M |
|
250
Manhattan Associates
MANH
$8.97B
| $1.08M | 0.01% |
21,806
+8,484
| +64% | +$381K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, ALPS Advisors held 913 positions worth $14.4B, up 2.4% from $14.1B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
ALPS Advisors deployed $578M of net new capital in Q4 2017, opening 139 new positions and adding to 302 existing holdings. Its largest new stake was NGL Energy Partners: 9,255,792 shares worth $130M.
By sector, the portfolio is most concentrated in Energy at 58% of assets, down from 58% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was T. Rowe Price, an estimated $53.8M trimmed.
- ALPS Advisors's largest Q4 2017 buy was NGL Energy Partners: 9,255,792 shares worth $130M.
- ALPS Advisors added most to Energy Transfer Partners, L.P. in Q4 2017, an estimated $112M increase.
- ALPS Advisors's biggest Q4 2017 reduction was T. Rowe Price, cutting an estimated $53.8M.
- ALPS Advisors fully exited The Mosaic Company in Q4 2017, selling an estimated $50.4M.
- ALPS Advisors's ten largest holdings make up 50% of its $14.4B portfolio in Q4 2017.
- ALPS Advisors opened 139 new positions and closed 73 in Q4 2017.
- ALPS Advisors's portfolio value rose 2.4% quarter-over-quarter to $14.4B.
Based on ALPS Advisors's 13F filing for Q4 2017, filed 5 Feb 2018.